SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Corinna Weber-Schöndorfer, Drugs During Pregnancy and Lactation, 2015,

    CrossRef

  2. 2
    Sally Rafie, Sophia Lai, Juanita E. Garcia, Sheila K. Mody, Contraceptive use in female recipients of a solid-organ transplant, Progress in Transplantation, 2014, 24, 4, 344

    CrossRef

  3. 3
    M. C. Soh, C. Nelson-Piercy, High-risk pregnancy and the rheumatologist, Rheumatology, 2014,

    CrossRef

  4. 4
    Kara M De Felice, Sunanda V Kane, Inflammatory bowel disease in women of reproductive age, Expert Review of Gastroenterology & Hepatology, 2014, 8, 4, 417

    CrossRef

  5. 5
    P. Deepak, D. J. Stobaugh, Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2014, 40, 9
  6. 6
    Bonnie L. Bermas, Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy, Current Opinion in Rheumatology, 2014, 26, 3, 334

    CrossRef

  7. 7
    A. J. Czaja, Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  8. 8
    Sura Alwan, Christina D. Chambers, Vincent T. Armenti, A. Dessa Sadovnick, The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS), Multiple Sclerosis and Related Disorders, 2014,

    CrossRef

  9. 9
    Simon A. Broadley, Michael H. Barnett, Mike Boggild, Bruce J. Brew, Helmut Butzkueven, Robert Heard, Suzanne Hodgkinson, Allan G. Kermode, Jeannette Lechner-Scott, Richard A.L. Macdonell, Mark Marriott, Deborah F. Mason, John Parratt, Stephen W. Reddel, Cameron P. Shaw, Mark Slee, Judith Spies, Bruce V. Taylor, William M. Carroll, Trevor J. Kilpatrick, John King, Pamela A. McCombe, John D. Pollard, Ernest Willoughby, Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations, Journal of Clinical Neuroscience, 2014, 21, 11, 1857

    CrossRef

  10. 10
    Medha Barbhaiya, Bonnie L. Bermas, Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy, Clinical Immunology, 2013, 149, 2, 225

    CrossRef

  11. 11
    Bram P. Wispelwey, Eyal Sheiner, Inflammatory bowel disease and preterm delivery, Archives of Gynecology and Obstetrics, 2013, 288, 4, 725

    CrossRef

  12. 12
    Susie W Ng, Uma Mahadevan, Management of inflammatory bowel disease in pregnancy, Expert Review of Clinical Immunology, 2013, 9, 2, 161

    CrossRef

  13. 13
    Iris Dotan, Arik Alper, Daniel Rachmilewitz, Eran Israeli, Shmuel Odes, Irit Chermesh, Timna Naftali, Gerald Fraser, Ariella Bar-Gil Shitrit, Vardit Peles, Shimon Reif, Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: A multicenter study in Israel, Journal of Crohn's and Colitis, 2013, 7, 7, 542

    CrossRef

  14. 14
    Kristina Muñoz-Flores Thiagarajan, Schweta R. Arakali, Kathleen J. Mealey, Elyce H. Cardonick, William J. Gaughan, John M. Davison, Michael J. Moritz, Vincent T. Armenti, Safety considerations: breastfeeding after transplant, Progress in Transplantation, 2013, 23, 2, 137

    CrossRef

  15. 15
    M J Casanova, M Chaparro, E Domènech, M Barreiro-de Acosta, F Bermejo, E Iglesias, F Gomollón, L Rodrigo, X Calvet, M Esteve, E García-Planella, S García-López, C Taxonera, M Calvo, M López, D Ginard, M Gómez-García, E Garrido, J L Pérez-Calle, B Beltrán, M Piqueras, C Saro, B Botella, C Dueñas, A Ponferrada, M Mañosa, V García-Sánchez, J Maté, J P Gisbert, Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease, The American Journal of Gastroenterology, 2013, 108, 3, 433

    CrossRef

  16. 16
    J. R. Hutson, J. N. Matlow, M. E. Moretti, G. Koren, The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy, Journal of Obstetrics & Gynaecology, 2013, 33, 1, 1

    CrossRef

  17. 17
    Inbal Braunstein, Victoria Werth, Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy, Dermatologic Therapy, 2013, 26, 4
  18. 18
    Andres Yarur, Sunanda V. Kane, Update on pregnancy and breastfeeding in the era of biologics, Digestive and Liver Disease, 2013, 45, 10, 787

    CrossRef

  19. 19
    Stefan Schanz, Wie sich Autoimmundermatosen auf das Sexualleben auswirken, MMW - Fortschritte der Medizin, 2013, 155, 11, 42

    CrossRef

  20. 20
    Andrew Smyth, Milan Radovic, Vesna D. Garovic, Women, Kidney Disease, and Pregnancy, Advances in Chronic Kidney Disease, 2013, 20, 5, 402

    CrossRef

  21. 21
    Krisztina Hagymási, Pál Miheller, Zsolt Tulassay, Adatok az „önként vállalt gyermektelenség” csökkentésére gyulladásos bélbetegségben, Orvosi Hetilap, 2012, 153, 47, 1855

    CrossRef

  22. 22
    Bethan Myers, Diagnosis and management of maternal thrombocytopenia in pregnancy, British Journal of Haematology, 2012, 158, 1
  23. 23
    Séverine Vermeire, Franck Carbonnel, Pierre G. Coulie, Vincent Geenen, Johanna M.W. Hazes, Pierre L. Masson, Filip De Keyser, Edouard Louis, Management of inflammatory bowel disease in pregnancy, Journal of Crohn's and Colitis, 2012, 6, 8, 811

    CrossRef

  24. 24
    Sura Alwan, A Dessa Sadovnick, Multiple sclerosis and pregnancy: maternal considerations, Women's Health, 2012, 8, 4, 399

    CrossRef

  25. 25
    Luc Biedermann, Gerhard Rogler, Stephan R. Vavricka, Frank Seibold, Mariam Seirafi, Pregnancy and Breastfeeding in Inflammatory Bowel Disease, Digestion, 2012, 86, s1, 45

    CrossRef

  26. 26
    Laura Andreoli, Micaela Fredi, Cecilia Nalli, Rossella Reggia, Andrea Lojacono, Mario Motta, Angela Tincani, Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome, Journal of Autoimmunity, 2012, 38, 2-3, J197

    CrossRef

  27. You have free access to this content27
    F. M. Habal, V. W. Huang, Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient, Alimentary Pharmacology & Therapeutics, 2012, 35, 5
  28. 28
    Sumona Saha, Arnold Wald, Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease, Expert Opinion on Drug Safety, 2012, 11, 6, 947

    CrossRef

  29. 29
    Mona Akbari, Sveta Shah, Fernando S. Velayos, Uma Mahadevan, Adam S. Cheifetz, Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease, Inflammatory Bowel Diseases, 2012, 18, 12
  30. 30
    May Ching Soh, Catherine Nelson-Piercy, Update of the management of rheumatoid arthritis in pregnancy, Expert Review of Obstetrics & Gynecology, 2012, 7, 1, 77

    CrossRef

  31. 31
    Arzneimittel in Schwangerschaft und Stillzeit, 2012,

    CrossRef

  32. 32
    A. Gouraud, T. Vial, Médicaments et Grossesse : Prescrire et évaluer le Risque, 2012,

    CrossRef

  33. 33
    John R. McArdle, Pregnancy in Cystic Fibrosis, Clinics in Chest Medicine, 2011, 32, 1, 111

    CrossRef

  34. 34
    J.R. Hutson, A. Lubetsky, A. Walfisch, B.G. Ballios, F. Garcia-Bournissen, G. Koren, The transfer of 6-mercaptopurine in the dually perfused human placenta, Reproductive Toxicology, 2011, 32, 3, 349

    CrossRef

  35. 35
    Deanna D. Nguyen, Thiopurines and paternity: Is it safe?, Inflammatory Bowel Diseases, 2011, 17, 11
  36. 36
    Ash HANAFY, César DIAZ-GARCIA, Michael OLAUSSON, Mats BRÄNNSTRÖM, Uterine transplantation: one human case followed by a decade of experimental research in animal models, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2011, 51, 3
  37. 37
    J.K. Aronson, A worldwide yearly survey of new data in adverse drug reactions, 2011,

    CrossRef

  38. 38
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 3
  39. 39
    K. Groth, M. Brannstrom, J. Molne, C.A. Wranning, Cyclosporine A exposure during pregnancy in mice: effects on reproductive performance in mothers and offspring, Human Reproduction, 2010, 25, 3, 697

    CrossRef

  40. 40
    C. Janneke van der Woude, Sanja Kolacek, Iris Dotan, Tom Øresland, Séverine Vermeire, Pia Munkholm, Uma Mahadevan, Lucy Mackillop, Axel Dignass, European evidenced-based consensus on reproduction in inflammatory bowel disease, Journal of Crohn's and Colitis, 2010, 4, 5, 493

    CrossRef

  41. 41
    Amy B Elliott, Eliza F Chakravarty, Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases, Women's Health, 2010, 6, 3, 431

    CrossRef

  42. 42
    Lola Y Kwan, Uma Mahadevan, Inflammatory bowel disease and pregnancy: an update, Expert Review of Clinical Immunology, 2010, 6, 4, 643

    CrossRef

  43. 43
    Lyn Colvin, Linda Slack-Smith, Fiona J. Stanley, Carol Bower, Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens, Pharmacoepidemiology and Drug Safety, 2010, 19, 11
  44. 44
    Javier P. Gisbert, Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding, Inflammatory Bowel Diseases, 2010, 16, 5
  45. 45
    S. Skalli, E. Ferreira, J.F. Bussieres, B. Allenet, Soins pharmaceutiques en gynécologie-obstétrique : à propos d’un cas, Le Pharmacien Hospitalier, 2010, 45, 3, 117

    CrossRef

  46. 46
    Christina Ha, Themistocles Dassopoulos, Thiopurine therapy in inflammatory bowel disease, Expert Review of Gastroenterology & Hepatology, 2010, 4, 5, 575

    CrossRef

  47. 47
    Barry J. Browne, Azathioprine,
  48. 48
    Serban Constantinescu, Veronica Gomez-Lobo, John M. Davison, Michael J. Moritz, Vincent T. Armenti, Pregnancy and Contraception in Transplantation,